The core activity of Probionova SA is the research and development of new probiotic strains and applications for therapeutic purposes, particularly in the field of human health and microbiome. The company develops clinically evidence-based probiotics with pharmaceutical quality for therapeutic applications and offers services such as the selection and development of probiotic strains, the manufacture of probiotic combinations, and the provision of full-service solutions.